You are raising a Series A round of $19M for AI documentation copilot that turns clinician-patient conversations into billing-ready notes. You closed a prior round on a story that worked. This one is different: the passes are polite, information-free, and you can't tell whether it's the market or the deck. It's the deck — specifically, its order, the metric you lead with, and whether the arithmetic on your ask survives the ten seconds a partner spends on it before reading a word.
A first read of a deck lasts about 3 minutes 44 seconds, and the first three slides decide whether the partner finishes (DocSend deck-analytics, public). In that window they are not reading your prose. They are checking three things, in this order:
This report answers all three from your inputs. What follows is the diagnosis, then the fix, then the checklist. First, your headline numbers.
| Company + one-liner | Fathom Clinical — AI documentation copilot that turns clinician-patient conversations into billing-ready notes |
| Stage + model | Series A · Vertical / applied AI |
| The ask | $19M |
| Metrics you provided | 7 of 8 rows filled |
“Great team, a little early for us.” “Not a fit for our thesis right now.” “Let's stay in touch.” These are not feedback. They are what a partner writes when the deck didn't earn the ten minutes it takes to write real feedback.
| The polite pass | What it usually means | Which section fixes it |
|---|---|---|
| “A little early for us” | Your metrics are being read against the wrong bar, or your lead metric is buried. | § Interest — Metrics vs. the stage bar |
| “Not a fit for our thesis” | The arc didn't land in the first three slides — the partner never got what you actually are. | § Interest — Your arc & slide order |
| “Need to see more traction” | The traction is there but presented in a form (cumulative, no axis) that hides it. | § Interest — Slide-by-slide & metric rules |
| Silence after data-room access | A number in the deck didn't reconcile with the data room — a silent, un-appealable no. | § Interest — Traction slide & consistency |
| “Why do you need $19M?” | The ask isn't milestone-anchored or isn't in-band for the stage. | § Interest — Red-flag detector on the ask |
| Attention — your situation | |
| Your situation, mirrored back | 2 |
| The diagnosis, in four numbers | 3 |
| How to read this report & your inputs | 4 |
| What a polite pass actually is | 5 |
| Interest — the analysis core | |
| 1 · Your narrative arc & transparent scoring | 7 |
| 2 · Your re-sequenced 11-slide outline | 13 |
| 3 · Metric-presentation rules vs. your stage bar | 32 |
| 4 · Red-flag detector on the ask | 40 |
| Desire — the transformation | |
| Before / after: your deck re-read | 47 |
| The roadmap & milestone timeline | 51 |
| Your next partner conversation, rewritten | 57 |
| Action — remove all doubt | |
| Prioritized checklist — this week / 30 / 90 days | 61 |
| Copy-paste scripts & templates | 64 |
| Advisor / lawyer handoff sheet | 68 |
| Your next step & guarantee | 70 |
We score five canonical funded-deck arcs against your inputs and pick the best fit. Your winning arc:
| Your one-liner | AI documentation copilot that turns clinician-patient conversations into billing-ready notes |
| Your stated why-now | Ambient-speech models crossed clinical-grade accuracy only in the last ~18 months, and 2024 CMS billing changes made documentation quality directly revenue-linked. |
| Your stated wedge | We own the specialty-specific billing-code layer that generic scribes miss, trained on a proprietary corpus of specialty encounters. |
| Stage / model / ARR | Series A · Vertical / applied AI · $2.4M ARR |
| Arc | Fit score | Relative fit |
|---|---|---|
| ▶ Platform / multi-product | 6 | |
| Category creation | 4 | |
| Efficiency play (10x on a known job) | 2 | |
| Sharp wedge → platform (default early-stage arc) | 2 | |
| Picks-and-shovels (arms dealer to a boom) | 1 |
Highest score wins. The runner-up (Category creation) is your fallback if your positioning shifts before you go out — e.g. if a metric moves or you re-cut the wedge. Rubric: https://irnarrative.co/methodology.
Every score above is the sum of the signal lines beneath it — the same rubric for all five arcs, public on https://irnarrative.co/methodology. You can reproduce any of these five numbers, not just the winner's.
| Selected arc | Platform / multi-product |
| Arc's opening sequence | Title / one-line purpose → Problem → Wedge / why you win |
| Weak wedge (a partner discounts) | Durable wedge (a partner underwrites) |
|---|---|
| “Better UX / easier to use” | Proprietary data that compounds with usage |
| A feature the incumbent can ship in a quarter | Distribution or workflow lock-in that's costly to switch |
| A 2×2 rigged so you're alone top-right | A structural cost edge you can quantify |
| An omitted competitor the partner already knows | Named competitors + the honest do-nothing / DIY status quo |
| Your stated wedge | We own the specialty-specific billing-code layer that generic scribes miss, trained on a proprietary corpus of specialty encounters. |
| Diligence lens on this slide | Whether the advantage is durable or a temporary feature lead an incumbent copies in a quarter. This is the defensibility question every partner returns to. |
You now have your arc, the score behind it, the runner-up to avoid, and your opening three slides. The next section takes all eleven slides and, for each, gives you the one question it must answer, exactly what to show, the specific thing the partner checks there, the failure that kills it, and notes tuned to your stage and model.
| # | Slide | Attention | Role in your arc |
|---|---|---|---|
| 1 | Title / one-line purpose | — | supporting |
| 2 | Problem | ~38s | supporting |
| 3 | Wedge / why you win | ~22s | supporting |
| 4 | Product | ~21s | supporting |
| 5 | Traction | ~49s | LOAD-BEARING |
| 6 | Business model & unit economics | ~30s | LOAD-BEARING |
| 7 | Market size | ~27s | LOAD-BEARING |
| 8 | Go-to-market | — | supporting |
| 9 | Why now | ~33s | supporting |
| 10 | Team | ~62s | supporting |
| 11 | The ask / use of funds | ~52s | supporting |
First-read totals ~3m44s across all slides (DocSend, public). Attention seconds travel with the slide TYPE, so they re-order with your arc. Load-bearing = the 2–3 slides that, per your arc, must be right.
| Selected arc | Platform / multi-product |
| Load-bearing slides | Traction, Business model & unit economics, Market size |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 1 of 11 |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 2 of 11 |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 3 of 11 |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 4 of 11 |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 5 of 11 (load-bearing) |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 6 of 11 (load-bearing) |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 7 of 11 (load-bearing) |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 8 of 11 |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 9 of 11 |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 10 of 11 |
| Your stage / model | Series A · Vertical / applied AI |
| Position in your arc | slide 11 of 11 |
| Slide | Traction (slide 5, load-bearing) |
| Metrics that surface here | ARR, YoY growth (revenue multiple), Gross margin, Net dollar retention (NDR), Burn multiple, MoM MRR growth, Logo retention, CAC payback (months) |
| Slide | Business model & unit economics (slide 6, load-bearing) |
| Metrics that surface here | ARR, YoY growth (revenue multiple), Gross margin, Net dollar retention (NDR), Burn multiple, MoM MRR growth, Logo retention, CAC payback (months) |
| Slide | Market size (slide 7, load-bearing) |
| Metrics that surface here | qualitative for your stage |
| Your primary market | US |
| Your model | Vertical / applied AI |
| Metric & role | You vs. bar | Status |
|---|---|---|
| ARR LEAD SLIDE |
$2.4M |
🟡 Clears the bar |
| YoY growth (revenue multiple) LEAD SLIDE |
2.7x |
🔴 Below the bar |
| Gross margin LEAD SLIDE |
41% |
🔴 Below the bar |
| Net dollar retention (NDR) LEAD SLIDE |
121% |
🟢 Strong |
| Burn multiple LEAD SLIDE |
3.4x |
🔴 Below the bar |
| MoM MRR growth support |
— not provided |
▫️ Not provided |
| Logo retention support |
91% |
🟢 Strong |
| CAC payback (months) support |
15mo |
🟡 Clears the bar |
Ranges: institutional consensus for US Vertical / applied AI, 2024–2026 (Bessemer, ICONIQ, OpenView/High Alpha, KeyBanc, Carta). Verify against source reports before quoting — methodology.
| You reported | $2.4M |
| Bar (stage × model) | Clears $1.5M · Strong $3M |
| Engine verdict | Clears the bar |
| You reported | 2.7x |
| Bar (stage × model) | Clears 3x · Strong 4x |
| Engine verdict | Below the bar |
| You reported | 41% |
| Bar (stage × model) | Clears 45% · Strong 55% |
| Engine verdict | Below the bar |
| You reported | 121% |
| Bar (stage × model) | Clears 100% · Strong 110% |
| Engine verdict | Strong |
| You reported | 3.4x |
| Bar (stage × model) | Clears ≤2x · Strong ≤1x |
| Engine verdict | Below the bar |
| You reported | — (blank) |
| Bar (stage × model) | Clears 7% · Strong 15% |
| Engine verdict | Not provided |
| You reported | 91% |
| Bar (stage × model) | Clears 80% · Strong 90% |
| Engine verdict | Strong |
| You reported | 15mo |
| Bar (stage × model) | Clears ≤18mo · Strong ≤12mo |
| Engine verdict | Clears the bar |
| Stage / model | Series A · Vertical / applied AI |
| Metrics you provided | 7 of 8 |
| Below the bar | 3 |
Sanity bands from Carta State of Private Markets (Q4 2025 / Q1 2026) and PitchBook-NVCA Venture Monitor (2025). These are arithmetic sanity checks, not a valuation opinion or a prediction of fundability.
| The ask you entered | $19M |
| Stage | Series A |
| ARR (for the multiple check) | $2.4M |
| Runway (for the milestone check) | 20 months |
Median post-money: Carta State of Private Markets (Q4 2025). Both the dilution band and the ~60× multiple ceiling are deliberately wide sanity bands, not valuation ranges — real Series A post-money runs several-fold wide within the stage by sector and growth. This is a check at the stage MEDIAN; confirm the real target post-money with whoever owns your cap table.
| The ask | $19M |
| Stage | Series A |
| The ask | $19M |
| Stage | Series A |
| Your ask | $19M |
| Your stated use of funds | Scale a specialty-by-specialty GTM motion and build the payer-integration layer. |
| Change | From → To | Section |
|---|---|---|
| Slide order | Template order → Platform / multi-product arc order (opens on Title / one-line purpose) | §1–2 |
| Lead metric | Buried → ARR, YoY growth (revenue multiple), Gross margin, Net dollar retention (NDR), Burn multiple on the traction slide | §3 |
| Below-bar metrics | Stated flat → YoY growth (revenue multiple), Gross margin, Burn multiple paired with the path-up context | §3 |
| The ask | $19M “for the team” → $19M to reach [next-round metric] | §4 |
A deck built against this report doesn't guarantee a term sheet — nothing honest can. What it does is remove the reasons a partner passes before understanding you. The polite passes stop being about your order, your buried metric, and your unanchored ask, and start being real conversations you can actually learn from.
| # | Slide | The one question it answers |
|---|---|---|
| 1 | Title / one-line purpose | What do you do, in one sentence a partner can repeat to the IC verbatim? |
| 2 | Problem | Whose pain is this, exactly, and how acute is it in dollars or hours? |
| 3 | Wedge / why you win | Why do you win the beachhead, and what durable advantage compounds as you scale? |
| 4 | Product | Does it work, and can I understand the core flow without you in the room? |
| 5 | Traction LB | Is this working, measured by a number I can verify from your systems? |
| 6 | Business model & unit economics LB | How do you make money, and are the unit economics real at the shown scale? |
| 7 | Market size LB | How big can this get, and do you actually know who pays and how much? |
| 8 | Go-to-market | How do you acquire customers repeatably, and does more capital buy more growth? |
| 9 | Why now | What changed recently that makes this possible/inevitable today, not 3 years ago? |
| 10 | Team | Why is THIS team the one that wins THIS problem? |
| 11 | The ask / use of funds | How much, for what, to reach which specific milestone? |
LB = load-bearing for your Platform / multi-product arc. Get those right first.
| Stage | What the round is underwritten on | Rough ARR bar |
|---|---|---|
| Pre-seed | Team + wedge + founder-problem fit | pre-revenue → ~$150K |
| Seed | Early revenue + a working motion | ~$100K–$1M |
| Series A | Repeatable growth + efficiency | ~$1.5M–$3M |
| Series B | Scale + durable unit economics | ~$5M–$10M |
Rough US medians, 2024–2026 (Carta, PitchBook-NVCA). Your row is highlighted; the next row down is the bar this round targets.
| Your stage | Series A |
| This round targets | the ~$5M+ ARR Series B bar |
| The objection your deck would have invited | How the fixed deck pre-answers it |
|---|---|
| “What's your ARR?” | It's on the traction slide, in the right form, leading. |
| “Isn't this a bit early?” | Metrics graded against the Series A bar, in context. |
| “Why do you need $19M?” | Milestone-anchored ask with a use-of-funds split. |
| “What exactly are you?” | The arc lands in the first three slides. |
You've seen the diagnosis, the fixes, the roadmap, and the conversation on the other side. The last section makes it executable: a prioritized checklist, copy-paste scripts for the slides that matter most, and a one-page handoff for your advisor or lawyer.
| Company / stage / model | Fathom Clinical · Series A · Vertical / applied AI |
| The ask | $19M |
| Implied dilution (median post) | 19.4% — confirm target post-money with your CFO/lawyer |
| Ask flags | 0 red, 2 watch (section 4) |
| Selected arc | Platform / multi-product (score 6) |
| Lead metrics | ARR, YoY growth (revenue multiple), Gross margin, Net dollar retention (NDR), Burn multiple |
| Below-bar metrics | YoY growth (revenue multiple), Gross margin, Burn multiple |
| Missing lead metrics | none |
For your advisor: everything here is deterministic and cites a public band. This is educational analysis, not legal, tax, or investment advice — the disclaimer applies (footer).
If this report is unusable, or was delivered later than promised, reply “refund” and it's processed within one business day. Flat fee, no success fee, no investor introductions.
An IR / Corporate Development operator who took a deep-tech company public end to end — running the full exchange listing review — and raised $50M+ across venture rounds. The narrative sequencing, bottom-up market math, and arithmetic sanity checks here are the same ones used from the operator's side of the table, restated from public frameworks (YC, Sequoia, NVCA, Carta, public exchange/SEC rules).
Educational analysis and an editorial/formatting service — not investment, legal, or tax advice, not a fairness or valuation opinion, and not a prediction of whether you will raise. All benchmark ranges are institutional consensus for US venture (2024–2026) from public reporting (Carta, PitchBook-NVCA, Bessemer, ICONIQ, OpenView/High Alpha, KeyBanc); verify against the source reports before quoting to an investor — markets move. IR Narrative does not introduce investors and charges a flat fee only, with no success fees and no personalized investment recommendations.
| Arc selection | Deterministic scoring of five canonical funded-deck arcs against your stage / model / metrics / stated why-now & wedge. Rubric public at https://irnarrative.co/methodology. |
| Slide sequence & diligence lenses | Distilled from public funded-deck craft (YC “How to Pitch,” Sequoia business-plan template, a16z/NFX public writing) and DocSend deck-analytics (public). |
| Metric bars | Institutional consensus for US venture, 2024–2026: Bessemer State of the Cloud, ICONIQ Growth, OpenView / High Alpha SaaS Benchmarks, KeyBanc, Carta State of Private Markets. |
| Round size / dilution / post-money | US medians: Carta State of Private Markets (Q4 2025 / Q1 2026), PitchBook-NVCA Venture Monitor (2025). |
| What this is NOT | Not a valuation, not a fairness opinion, not a prediction of fundability, not investment/legal/tax advice. Verify every band against the source before quoting — markets move. |